PointState Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-170,000
Closed -$10.8M 183
2013
Q3
$10.8M Buy
+170,000
New +$10.8M 0.18% 73